Fact CheckerSign in

NCT06824311Completed

Clinical Characteristics and Outcome of Patients With Hemorrhagic Stroke Admitted in Neurology Department in a Tertiary Hospital

Source: ClinicalTrials.gov · Last updated 14 Feb 2025

Brief summary (registry, in English)

The main aim of this study is to know about the clinical profile of patients who are diagnosed as hemorrhagic stroke as well as the factors that affect good and bad outcomes of those patients after 3 months. Patients will be required to follow up in medical OPD of the same institution after 3 months.

Status (registry)
Completed
Study type
Observational
Enrollment
197 (actual)
First submitted
7 Feb 2025
Start date
1 Apr 2023
Primary completion date
31 Mar 2024
Lead sponsor
Tribhuvan University Teaching Hospital, Institute Of Medicine.
Diseases
Stroke
NCT number
NCT06824311

What you commit to

  • Study type: Observational
  • Participants enrolled: 197
  • From 1 Apr 2023 to the primary completion date, 31 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Post-traumatic hemorrhages, hemorrhagic transformation of an ischemic stroke, or any intracranial hemorrhages other than primary intracranial hemorrhages were excluded from the study

Other

  • Does not give consent

Who the study is looking for

  • Diagnosed case of hemorrhagic stroke

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tribhuvan University Teaching Hospital
Coordinator of this site? Confirm its status
MaharajgunjNepalUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.